Cure with omeprazole plus amoxicillin versus long-term ranitidine therapy in Helicobacter pylori-associated peptic ulcer bleeding

被引:54
作者
Riemann, JF [1 ]
Schilling, D [1 ]
Schauwecker, P [1 ]
Wehlen, G [1 ]
Dorlars, D [1 ]
Kohler, B [1 ]
Maier, M [1 ]
机构
[1] UNIV MAINZ,DEPT GASTROENTEROL & HEPATOL,KLINIKUM STADT LUDWIGSHAFEN,ACAD HOSP,LUDWIGSHAFEN,GERMANY
关键词
D O I
10.1016/S0016-5107(97)70114-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Long-term prophylaxis with ranitidine reduces the risk of recurrent bleeding in patients with a history of bleeding peptic ulcers. To date, no randomized study has been performed to compare cure of Helicobacter pylori infection versus H2 blocker prophylaxis in patients with bleeding peptic ulcer. Methods: In a prospective randomized study, 95 consecutive patients with H. pylori-associated peptic ulcer bleeding were randomized to either ranitidine prophylaxis (150 mg at night) for 2 years or to H. pylori-eradication with omeprazole 60 mg twice daily plus amoxicillin 750 mg three times daily for 10 days. Results: (Intention-to-treat analysis). Forty-eight patients were enrolled in the ranitidine group; 47 in the omeprazole-plus-amoxicillin group. Mean follow-up was 576 days (77 to 730). Ulcer recurrence rate was 31.3% in the ranitidine group (group 1) versus 6.37% in the eradication group (group 2; p = 0.0018). More patients had recurrent bleeding in group 1 (8.3%) than in group 2 (4.2%) but we were not able to show a statistically significant difference with respect to recurrent bleeding between groups (p = 0.29). Definite cure of H. pylori infection was achieved in 89.3%. Conclusions: Cure of H. pylori infection reduces recurrence of peptic ulcer and therefore rebleeding more effectively than does long-term maintenance therapy with an H2 blocker.
引用
收藏
页码:299 / 304
页数:6
相关论文
共 24 条
[1]   RUDER - A PROSPECTIVE, 2-YEAR, MULTICENTER STUDY OF RISK-FACTORS FOR DUODENAL-ULCER RELAPSE DURING MAINTENANCE THERAPY WITH RANITIDINE [J].
ARMSTRONG, D ;
ARNOLD, R ;
CLASSEN, M ;
FISCHER, M ;
GOEBELL, H ;
SCHEPP, W ;
BLUM, AL .
DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (07) :1425-1433
[2]  
BAYERDORFFER E, 1992, EUR J GASTROEN HEPAT, V4, P697
[3]   SHORT-TERM LOW-DOSE TRIPLE THERAPY FOR THE ERADICATION OF HELICOBACTER-PYLORI [J].
BAZZOLI, F ;
ZAGARI, RM ;
FOSSI, S ;
POZZATO, P ;
ALAMPI, G ;
SIMONI, P ;
SOTTILI, S ;
RODA, A ;
RODA, E .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1994, 6 (09) :773-777
[4]  
BLUM AL, 1990, ULKUSALMANACH 1 PLUS, P11
[5]   CLINICAL FACTORS IN THE PREDICTION OF FURTHER HEMORRHAGE OR MORTALITY IN ACUTE UPPER GASTROINTESTINAL HEMORRHAGE [J].
CLASON, AE ;
MACLEOD, DAD ;
ELTON, RA .
BRITISH JOURNAL OF SURGERY, 1986, 73 (12) :985-987
[6]   Effect of proton pump inhibitors on the detection of Helicobacter pylori in gastric biopsies [J].
Dickey, W ;
Kenny, BD ;
McConnell, JB .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 (03) :289-293
[7]   MULTICENTER PROSPECTIVE-STUDY OF THE CURRENT STATE OF TREATMENT IN GERMANY OF BLEEDING PEPTIC-ULCER [J].
ELL, C ;
HAHN, EG ;
HAGENMULLER, F ;
SCHMITT, W ;
RIEMANN, JF ;
HOHENBERGER, W .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1995, 120 (1-2) :3-9
[8]   PEPTIC-ULCER HEMORRHAGE - FACTORS PREDISPOSING TO RECURRENCE [J].
FISCHER, L ;
MADSEN, MR ;
THOMSEN, H ;
HOST, V ;
WARA, P .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1994, 29 (05) :414-418
[9]   TREATMENT OF HELICOBACTER-PYLORI REDUCES THE RATE OF REBLEEDING IN PEPTIC-ULCER DISEASE [J].
GRAHAM, DY ;
HEPPS, KS ;
RAMIREZ, FC ;
LEW, GM ;
SAEED, ZA .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1993, 28 (11) :939-942
[10]  
Graham DY, 1996, AM J GASTROENTEROL, V91, P2120